No significant impact on imputed arterial partial pressure of oxygen to fraction of inspired oxygen ratio at seven days
Low Dengue Incidence in 2020 Due to COVID-19-Related Disruption
Strongest evidence of association with reduced risk for measures related to school closures, reduced time spent in nonresidential areas
Single-Dose Malaria Relapse Pill Approved in Australia
Medicines for Malaria Venture (MMV) recently announced that the Australian Therapeutic Goods Administration (TGA) had approved the use of single-dose Kozenis (tafenoquine) in children in combination with chloroquine for the prevention of relapse of Plasmodium vivax (P. vivax) malaria.
The TGA approval confirmed on March 14, 2022, includes a novel, 50 mg dispersible tablet that can be dispersed in water and developed by GSK in partnership with MMV to facilitate use in children who are disproportionately affected by the disease.
2016 to 2020 Saw Anxiety, Depression Increase Among Children
From 2019 to 2020, increases seen in behavior or conduct problems and decreases seen in preventive medical visits
Prevalence of Depression Up Among Those Diagnosed With COVID-19
Prevalence of symptoms of depression and anxiety increased among those with COVID-19 who were bedridden for more than seven days
Rise in U.K. COVID-19 Cases Closely Watched by U.S. Health Officials
U.K. saw a 48 percent increase in COVID-19 cases and a 17 percent rise in hospitalizations last week
Containing Omicron Outbreaks Requires Ten Day Quarantine
The U.S. CDC recently published a Research Letter that determined the optimal quarantine duration after a person is exposed to the SARS-CoV-2 virus variant known as Omicron.
These researchers with South Korea’s CDC evaluated the time from exposure to diagnosis for 107 close contacts of Omicron patients.
They found the average time from exposure to diagnosis was 3.7 days.
Furthermore, 70% of diagnoses were made on day 5 and 99.1% by day 10, suggesting a 10-day quarantine protocol is appropriate.
Dengue Epidemics Curtailed by COVID-19 Pandemic
The COVID-19 pandemic has resulted in measurable disruptions in infectious disease dynamics such as dengue, an expanding acute public health threat in southeast Asia and Latin America.
The peer-review journal The Lancet published a study on March 4, 2022, that reported COVID-19-related disruption led to historically low dengue incidence in most countries in 2020.
This study showed the sudden decline in dengue cases in April 2020 was associated with the sudden changes in human movement behaviors.
Insights From the Northern Hemisphere's Flu Season 2022
The Georgia-based U.S. Centers for Disease Control and Prevention (CDC) recently reported the seasonal influenza vaccines selected for the 2021-2022 flu season were suboptimal at reducing outpatient respiratory illnesses caused by influenza A(H3N2) viruses.
The CDC’s Morbidity and Mortality Weekly Report (MMWR) found the overall vaccine effectiveness (VE) against medically attended outpatient acute respiratory infection (ARI) associated with influenza A(H3N2) virus was 16% (95% CI = −16% to 39%), which was considered not statistically significant.
Peripheral Neuropathy Observed in Patients With ‘Long COVID’
Prolonged small-fiber neuropathy after mild infection most common scenario in small sample of referred patients with WHO-defined long COVID